Peri-myocarditis caused by topical rectal mesalamine
Benjamin Koslowsky1,2, Amir Orlev3,4
1Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. binyaminkos@szmc.org.il.
Abstract:
Peri-myocarditis has been associated to mesalamine use. The definite association and use of topical rectal mesalamine to peri-myocarditis is not commonly known. In this case, we present a 46-year-old male exposed repeatedly to mesalamine with repeated peri-myocarditis. The relation to the medication was definite. Although an uncommon side effect of mesalamine, the possibility of peri or myocarditis should be considered. Awareness and early recognition may avoid potentially severe complications.
Insights
Mesalamine, a medication, can cause peri-myocarditis, an inflammation of the heart lining and muscle. This case highlights the definite link between topical rectal mesalamine and recurrent peri-myocarditis, emphasizing the need for awareness.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Peri-myocarditis is a known, albeit uncommon, adverse effect associated with mesalamine use.
- The specific link between topical rectal mesalamine and peri-myocarditis is not widely recognized.
Observation:
- A 46-year-old male patient experienced recurrent episodes of peri-myocarditis.
- The patient had a history of repeated exposure to mesalamine.
Findings:
- A definite association was established between the patient's mesalamine exposure and the development of peri-myocarditis.
- The recurrent nature of the condition strongly correlated with repeated mesalamine administration.
Implications:
- Clinicians should consider peri-myocarditis in patients using mesalamine, particularly when using topical rectal formulations.
- Early recognition and diagnosis of mesalamine-induced peri-myocarditis are crucial to prevent severe cardiac complications.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Myocarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Myocarditis II: Clinical Features and Diagnostic Tests


